shows potential for extending flare-free periods in patients with glucocorticoid-dependent polymyalgia rheumatica (PMR), with the ability to reduce glucocorticoid dose. In a phase 2 randomized ...

Both polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) present with a broad spectrum of clinical manifestations ... procedures as well as ongoing research on biomarkers and ...

Patients presenting with isolated extracranial manifestations of giant cell arteritis represent a distinct phenotype that is associated with younger age at diagnosis and more frequent polymyalgia ...

Diagnosing polymyalgia rheumatica involves a combination of clinical evaluation, patient history and diagnostic tests: Taking the patient's age into account is important because the disease ...